Market Tracker

09/02 10:10am ET
73.47
Real-Time Quote
 +0.015 / +0.02%
Today’s Change
10.95
Today|||52-Week Range
73.52
+398.74%
Year-to-Date

Today’s Trading

Previous close73.45
Today’s open73.37
Day’s range73.37 - 73.52
Volume1,650,413
Average volume (3 months)3,442,186
Market cap$7.9B
Dividend yield--
Data as of 9:55am ET, 09/02/2014

Growth & Valuation

Earnings growth (last year)-17.39%
Earnings growth (this year)-1.59%
Earnings growth (next 5 years)+60.00%
Revenue growth (last year)+168.74%
P/E ratioNM
Price/Sales17.04
Price/Book49.01

Competitors

 Today’s
change
Today’s
% change
GRFSGrifols SA-0.30-0.75%
GEVASynageva BioPharma C...-0.92-1.27%
XONIntrexon Corp-0.49-2.42%
OPHTOphthotech Corp-0.34-0.87%
Data as of 10:10am ET, 09/02/2014

Financials

Next reporting dateNovember 6, 2014
EPS forecast (this quarter)-$0.68
Annual revenue (last year)$70.3M
Annual profit (last year)-$219.6M
Net profit margin-313.88%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Daniel G. Welch
Executive VP, Chief Financial &
Accounting Officer
John C. Hodgman
Corporate headquarters
Brisbane, California

Forecasts